Matthew Kane's Insider Trades & SAST Disclosures

Matthew Kane's most recent trade in Flexsteel Industries, Inc. was a trade of 1,316 Common Stock done . Disclosure was reported to the exchange on Dec. 14, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Flexsteel Ind Inc
Kaness A. Matthew Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2023 1,316 45,016 (0%) 0% 0 Common Stock
Flexsteel Ind Inc
Matthew A. Kaness Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Sep 2023 1,184 43,700 (0%) 0% 0 Common Stock
Flexsteel Ind Inc
Matthew A. Kaness Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 1,161 42,516 (0%) 0% 0 Common Stock
Flexsteel Ind Inc
Matthew A. Kaness Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2023 1,138 41,355 (0%) 0% 0 Common Stock
Flexsteel Ind Inc
Matthew A. Kaness Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2022 1,234 40,217 (0%) 0% 0 Common Stock
Flexsteel Ind Inc
Matthew A. Kaness Director Grant, award, or other acquisition of securities at price $ 15.69 per share. 15 Sep 2022 1,115 38,983 (0%) 0% 15.7 17,494 Common Stock
Flexsteel Ind Inc
Matthew A. Kaness Director Grant, award, or other acquisition of securities at price $ 18.45 per share. 16 Jun 2022 949 37,868 (0%) 0% 18.4 17,509 Common Stock
Akerna Corp
Matthew R. Kane Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Apr 2022 3,486 10,458 - - Restricted Stock Units
Akerna Corp
Matthew R. Kane Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Apr 2022 3,486 351,967 (2%) 0% - Common Shares
Flexsteel Ind Inc
Matthew A. Kaness Director Grant, award, or other acquisition of securities at price $ 19.57 per share. 10 Mar 2022 894 36,919 (0%) 0% 19.6 17,496 Common Stock
Akerna Corp
Matthew R. Kane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 13,944 13,944 - - Restricted Stock Units
Flexsteel Ind Inc
Matthew A. Kaness Director Grant, award, or other acquisition of securities at price $ 30.50 per share. 09 Dec 2021 574 36,025 (0%) 0% 30.5 17,507 Common Stock
Akerna Corp
Matthew R. Kane Director Purchase of securities on an exchange or from another person at price $ 2.70 per share. 06 Oct 2021 128,160 131,928 (1%) 0% 2.7 346,032 Common Shares
Flexsteel Ind Inc
Matthew A. Kaness Director Purchase of securities on an exchange or from another person at price $ 29.88 per share. 05 Oct 2021 112 35,451 (0%) 0% 29.9 3,347 Common Stock
Flexsteel Ind Inc
Matthew A. Kaness Director Grant, award, or other acquisition of securities at price $ 34.98 per share. 09 Sep 2021 501 35,339 (0%) 0% 35.0 17,525 Common Stock
Akerna Corp
Matthew R. Kane Director Purchase of securities on an exchange or from another person at price $ 2.70 per share. 04 Aug 2021 11,299 145,081 (1%) 0% 2.7 30,507 Common Shares
Akerna Corp
Matthew R. Kane Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Aug 2021 1,854 0 - - Restricted Stock Units
Akerna Corp
Matthew R. Kane Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Aug 2021 1,854 133,782 (1%) 0% 0 Common Shares
Flexsteel Ind Inc
Matthew A. Kaness Director Purchase of securities on an exchange or from another person at price $ 39.22 per share. 16 Jul 2021 85 34,838 (0%) 0% 39.2 3,334 Common Stock
Flexsteel Ind Inc
Matthew A. Kaness Director Grant, award, or other acquisition of securities at price $ 43.66 per share. 17 Jun 2021 400 34,752 (0%) 0% 43.7 17,464 Common Stock
Precision Biosciences Inc
Matthew Kane Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 1,312 1,312 - - Employee Stock Option (Right to Buy)
Precision Biosciences Inc
Matthew Kane Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 763 763 - - Restricted Stock Units
Precision Biosciences Inc
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 13 May 2021 21,514 2,023,272 (3%) 0% 0.0 861 Common Stock
Precision Biosciences Inc
Matthew Kane Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 May 2021 21,514 0 - - Employee Stock Option (Right to Buy)
Precision Biosciences Inc
Matthew Kane Director, President and CEO Sale of securities on an exchange or to another person at price $ 8.96 per share. 13 May 2021 9,675 2,013,597 (3%) 0% 9.0 86,688 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades